Novartis Archives - chatsaudicam.com

Novartis Investigational STAMP Inhibitor Asciminib (ABL001) Shows Superior MMR Rate to Bosulif®* in Chronic Myeloid Leukemia Trial

12/10/2020 (ABL001), Asciminib, Bosulif®*, chronic, In, inhibitor, Investigational, Leukemia, MMR, Myeloid, Novartis, rate, shows, STAMP, Superior, to, trial

EAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)

Read more

New Novartis Analyses for Investigational Inclisiran Demonstrate Consistently Effective and Sustained LDL-C Reduction at Month 17, Regardless of Age and Gender

11/16/2020 17, age, analyses, and, at, Consistently, Demonstrate, effective, for, Gender, Inclisiran, Investigational, LDL-C, month, new, Novartis, of, Reduction, Regardless, Sustained

EAST HANOVER, N.J., Nov. 13, 2020 /PRNewswire/ — Novartis today announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and

Read more